Washington, [US], September 22 (ANI): Although people of any age can be infected with SARS-CoV-2, the virus that causes COVID-19, elderly patients face a higher risk of severity and death than younger patients. New research, comparing the immune response among age groups, may help explain wh
Washington [US], August 11 (ANI): A high-rate of asymptomatic COVID-19 cases is a "good thing" for the society and could play a role in the ending of the pandemic, according to a researcher.
Washington D.C. [USA], Mar 9 (ANI): Babies born before 32 weeks' gestation can rapidly acquire some adult immune factors after birth, equivalent to that achieved by infants born at term, finds a recent research.
Washington D.C. [USA], Jan 31 (ANI): Researchers discovered that using an immunotherapy drug called NKTR-214, also known as bempegaldesleukin, in combination with an infusion of anti-tumour immune cells, or T cells, may produce a stronger immune response that could help fight advanced melano
Washington D.C. [USA], Jan 4 (ANI): Several different chemical compounds found in creams and cosmetics can cause allergic reactions on the skin, but how the reaction gets triggered has been a mystery. However, now a study has suggested possible reasons why some chemicals trigger dermatitis.
Washington D.C. [USA], Nov 15 (ANI): Scientists seem to have cracked the secret of longevity of supercentenarians -those over the age of 110 years. New studies have found that these really old people possess an excess of cytotoxic CD4 T, a type of immune cells.
Washington D.C. [USA], July 22 (ANI): In a recent study it has been found that cell therapies is one of the first steps in developing personalised treatments for cancer in people.
Washington D.C. [USA], May 18 (ANI): Researchers have shown how skin vaccination can generate protective CD8 T-cells that are recruited to the genital tissues and could be used as a vaccination strategy for sexually transmitted infections (STIs).
Washington D.C. [USA], Feb 15 (ANI): A research team has now discovered that an immune checkpoint molecule they developed for cancer immunotherapy, also protects against future development of multiple types of cancer when administered by itself.
Washington D.C. [USA], Sep 08 (ANI): Turns out, disease-fighting T cells, elicited from vaccines, do not require glucose for their rapid reproduction, which may help the development of immunotherapy for cancer patients, a new study has revealed.
Washington D.C. [USA], August 3 (ANI): According to a new study, a group of scientists have revealed, for the first time, a method to reprogram specific T cells.